Zymeworks Common Stock Stock Price Prediction

ZYME Stock  USD 14.09  0.33  2.29%   
At the present time, The RSI of Zymeworks Common's share price is at 55. This usually means that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Zymeworks Common, making its price go up or down.

Oversold Vs Overbought

55

 
Oversold
 
Overbought
The successful prediction of Zymeworks Common's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Zymeworks Common and does not consider all of the tangible or intangible factors available from Zymeworks Common's fundamental data. We analyze noise-free headlines and recent hype associated with Zymeworks Common Stock, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Zymeworks Common's stock price prediction:
EPS Estimate Next Quarter
0.15
EPS Estimate Current Year
(1.41)
EPS Estimate Next Year
(1.52)
Wall Street Target Price
17.8556
EPS Estimate Current Quarter
(0.40)
Using Zymeworks Common hype-based prediction, you can estimate the value of Zymeworks Common Stock from the perspective of Zymeworks Common response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Zymeworks Common to buy its stock at a price that has no basis in reality. In that case, they are not buying Zymeworks because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Zymeworks Common after-hype prediction price

    
  USD 14.09  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Zymeworks Common Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
11.4014.2917.18
Details
Naive
Forecast
LowNextHigh
9.8312.7215.61
Details
9 Analysts
Consensus
LowTargetHigh
12.7113.9715.51
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.5-0.35-0.09
Details

Zymeworks Common After-Hype Price Prediction Density Analysis

As far as predicting the price of Zymeworks Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Zymeworks Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Zymeworks Common, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Zymeworks Common Estimiated After-Hype Price Volatility

In the context of predicting Zymeworks Common's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Zymeworks Common's historical news coverage. Zymeworks Common's after-hype downside and upside margins for the prediction period are 11.20 and 16.98, respectively. We have considered Zymeworks Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
14.09
14.09
After-hype Price
16.98
Upside
Zymeworks Common is not too volatile at this time. Analysis and calculation of next after-hype price of Zymeworks Common Stock is based on 3 months time horizon.

Zymeworks Common Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Zymeworks Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zymeworks Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Zymeworks Common, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.36 
2.89
  0.01 
  0.06 
22 Events / Month
19 Events / Month
In about 22 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
14.09
14.09
0.00 
7,225  
Notes

Zymeworks Common Hype Timeline

Zymeworks Common Stock is at this time traded for 14.09. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.06. Zymeworks is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.36%. %. The volatility of related hype on Zymeworks Common is about 1811.17%, with the expected price after the next announcement by competition of 14.15. About 99.0% of the company outstanding shares are owned by institutional investors. The book value of Zymeworks Common was at this time reported as 5.27. The company recorded a loss per share of 1.49. Zymeworks Common Stock had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 22 days.
Check out Zymeworks Common Basic Forecasting Models to cross-verify your projections.

Zymeworks Common Related Hype Analysis

Having access to credible news sources related to Zymeworks Common's direct competition is more important than ever and may enhance your ability to predict Zymeworks Common's future price movements. Getting to know how Zymeworks Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Zymeworks Common may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
DAWNDay One Biopharmaceuticals 0.27 10 per month 2.77 (0.05) 3.84 (3.69) 11.44 
INZYInozyme Pharma(0.17)9 per month 0.00 (0.31) 5.07 (7.92) 16.62 
ZNTLZentalis Pharmaceuticals Llc 0.05 9 per month 5.06  0.05  11.41 (8.64) 33.76 
SNDXSyndax Pharmaceuticals 0.06 7 per month 0.00 (0.09) 4.02 (4.33) 34.00 
PTGXProtagonist Therapeutics(0.06)9 per month 2.31 (0.02) 3.70 (3.74) 14.61 
RVMDRevolution Medicines 1.10 9 per month 2.00  0.14  4.81 (3.24) 10.95 
BPMCBlueprint Medicines Corp(0.37)10 per month 2.57 (0.02) 4.90 (3.62) 14.28 
STOKStoke Therapeutics(0.04)10 per month 0.00 (0.07) 4.68 (6.99) 21.35 
CYTKCytokinetics(0.83)10 per month 0.00 (0.08) 3.52 (4.15) 14.08 
RLAYRelay Therapeutics(0.03)11 per month 0.00 (0.06) 4.82 (6.29) 66.18 
PRQRProQR Therapeutics BV(0.22)7 per month 2.31  0.10  7.14 (4.95) 129.77 
ANNXAnnexon(0.02)10 per month 0.00 (0.06) 6.98 (5.26) 23.00 
ARWRArrowhead Pharmaceuticals 0.21 7 per month 3.16  0.02  6.14 (3.86) 19.44 
TERNTerns Pharmaceuticals 0.03 11 per month 0.00 (0.07) 6.02 (5.96) 34.09 
AKROAkero Therapeutics(0.28)9 per month 2.62  0.06  5.23 (4.45) 13.37 
EDITEditas Medicine(0.05)7 per month 0.00 (0.19) 7.41 (6.68) 24.40 
APLSApellis Pharmaceuticals 2.68 8 per month 0.00 (0.07) 4.48 (5.17) 15.97 
CABACabaletta Bio(0.29)7 per month 0.00 (0.05) 10.80 (10.89) 30.64 
ALECAlector 0.04 9 per month 0.00 (0.14) 8.66 (8.42) 44.59 
BLUEBluebird bio(0.01)12 per month 0.00 (0.12) 7.89 (9.62) 23.25 
MRSNMersana Therapeutics 0.22 9 per month 5.02  0.11  12.03 (9.72) 32.25 
YMABY mAbs Therapeutics 1.68 9 per month 0.00 (0.12) 5.00 (5.31) 22.06 
TVTXTravere Therapeutics(0.30)10 per month 1.95  0.24  11.58 (4.13) 23.97 

Zymeworks Common Additional Predictive Modules

Most predictive techniques to examine Zymeworks price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Zymeworks using various technical indicators. When you analyze Zymeworks charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Zymeworks Common Predictive Indicators

The successful prediction of Zymeworks Common stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Zymeworks Common Stock, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Zymeworks Common based on analysis of Zymeworks Common hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Zymeworks Common's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Zymeworks Common's related companies.
 2021 2022 2023 2024 (projected)
Graham Number20.918.0116.1811.22
Receivables Turnover1.7112.353.93.71

Story Coverage note for Zymeworks Common

The number of cover stories for Zymeworks Common depends on current market conditions and Zymeworks Common's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Zymeworks Common is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Zymeworks Common's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Zymeworks Common Short Properties

Zymeworks Common's future price predictability will typically decrease when Zymeworks Common's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Zymeworks Common Stock often depends not only on the future outlook of the potential Zymeworks Common's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zymeworks Common's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding68.9 M
Cash And Short Term Investments374.3 M

Complementary Tools for Zymeworks Stock analysis

When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.